Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors
Clinical trial NCT06835387 · RECRUITING
Trial details
- NCT number
- NCT06835387
- Sponsor
- Tiago Biachi de Castria
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.